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Abstract
Purpose We evaluated the diagnostic accuracy of attenua-
tion corrected nuclear myocardial perfusion imaging (MPI)
with a novel hybrid single photon emission computed
tomography (SPECT)/CT device consisting of an ultrafast
dedicated cardiac gamma camera with cadmium-zinc-
telluride (CZT) solid-state semiconductor detectors inte-
grated onto a multislice CT scanner to detect coronary
artery disease (CAD). Invasive coronary angiography
served as the standard of reference.
Methods The study population included 66 patients
(79% men; mean age 63±11 years) who underwent
1-day 99mTc-tetrofosmin pharmacological stress/rest ex-
amination and angiography within 3 months. Sensitivity,
specificity, positive predictive value (PPV) and negative
predictive value (NPV) as well as accuracy of the CT
X-ray based attenuation corrected CZT MPI for detection
of CAD (≥50% luminal narrowing) was calculated on a
per-patient basis.
Results The prevalence of angiographic CAD in the study
population was 82%. Sensitivity, specificity, PPV, NPV and
accuracy were 87, 67, 92, 53 and 83%, respectively.
Conclusion In this first report on CZT SPECT/CT MPI
comparison versus angiography we confirm a high accuracy
for detection of angiographically documented CAD.
Keywords CZT. SPECT.MPI . Invasive coronary
angiography . Accuracy . Attenuation correction
Introduction
Several types of gamma cameras have recently been
introduced with semiconductor detector material [1] instead
of the conventional sodium iodine (NaI) crystals. The
cadmium-zinc-telluride (CZT) semiconductors directly
convert radiation into electric signals without any of the
steps of violet light production, transport and conversion as
occurs in NaI crystals. The new CZT technology is
extremely compact and this miniaturization has enabled
different vendors to design a stationary array of 9 [2] to
19 [3–5] pinhole gamma cameras packed closely and
focused on the heart. The serial alignment of 19 detectors
in the camera used in the present study allows coverage of
the entire heart at all times, rendering time-consuming
camera rotation around the patient unnecessary. The
combination of the new CZT detector material and the
geometry with simultaneous acquisition of all views
necessary for tomographic reconstruction complemented
by innovative iterative reconstruction algorithms has
allowed shortening of scan duration from 15 min down
to 2–3 min [6]. A recent clinical validation study has
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documented an excellent comparability of the CZT device
and single photon emission computed tomography
(SPECT) results with regard to both perfusion and
functional data such as ejection fraction [4]. Despite these
remarkable refinements, the discrimination of soft tissue
artefacts from real perfusion defects has remained a
challenge. In fact, perfusion images acquired with CZT
detectors have recently been shown to benefit from X-ray
based CT attenuation correction validated for a CZT
detector camera [3]. Consequently, and as a result of the
trend towards hybrid devices, a first combined CZT
camera integrated onto a multislice CT camera has been
developed (Discovery NM/CT 570c, GE Healthcare). We
report here the first validation of CT attenuation corrected
myocardial perfusion imaging (MPI) by a CZT/CT device
using invasive coronary angiography as the standard of
reference.
Materials and methods
Study population
A total of 66 patients underwent stress/rest MPI on a
CZT/64-slice CT camera (Discovery NM/CT 570c, GE
Healthcare) and invasive coronary angiography within
3 months of the MPI. Patients with non-ischaemic
cardiomyopathy, valvular heart disease, left bundle
branch block or prior coronary artery bypass grafting
were excluded. Written informed consent was obtained
from all patients for the use of their clinical and imaging
data for research purposes as approved by the Institu-
tional Review Board (local Ethics Committee).
Study protocol
A 1-day 99mTc-tetrofosmin stress/rest imaging protocol
was applied to all patients in accordance with the guide-
lines of the European Association of Nuclear Medicine
(EANM) [7]. All patients were asked to refrain from
caffeine-containing food and beverages for at least 12 h.
Pharmacological stress was induced either by standard
adenosine (continuous 6-min administration at 140 μg/kg
per min) or dobutamine (incrementally administered,
starting at 5 μg/kg per min and increasing at 1-min
intervals to a maximal dose of 60 μg/kg per min until
85% of the age-predicted heart rate had been achieved).
99mTc-tetrofosmin was administered after 3 min of induced
stress. After a waiting period of 45–60 min [7] (up to
90 min), images were acquired using the CZT/CT camera.
Rest MPI was subsequently acquired with the identical
acquisition protocol after administration of a three times
higher dose of 99mTc-tetrofosmin.
Image acquisition
CZT/CT camera (Discovery NM/CT 570c, GE Healthcare)
scans were acquired using a multi-pinhole collimator
(effective diameter aperture of 5.1 mm) and 19 stationary
detectors simultaneously imaging 19 different views of the
heart. Each detector contains 32×32 pixelated (2.46×
2.46 mm) CZT elements. The system design allows
acquisition without detector or collimator motion. A 10%
symmetrical energy window at 140 keV was used. Scans
with the CZT camera were acquired over 3 min for stress
and 2 min for rest [6].
X-ray based attenuation maps
All patients underwent an unenhanced 64-slice CT
examination on the CT part of the hybrid device during a
breath-hold and with prospective ECG triggering at 75% of
the R-R interval as previously reported in detail [3]. Briefly,
after acquisition with 2.5 mm section thickness, 0.35 s
gantry rotation times and 120 kV at 200–250 mAs (depend-
ing on patient’s size) attenuation maps were reconstructed on
a Xeleris workstation (GE Healthcare) [8] with 5.0 mm
thickness with a 512 × 512 matrix and a full chest size-
adapted field of view of 50 × 50 cm.
MPI image reconstruction
CZT/CT images were reconstructed as previously reported
[4, 6] on the same workstation as was used for CT
attenuation maps applying an iterative reconstruction
algorithm with maximum likelihood expectation maximi-
zation (MLEM). The software Myovation for Alcyone
(GE Healthcare) was used for analysis and a Butterworth
postfilter was applied to the reconstructed slices. All
attenuation corrected images were reconstructed in standard
axes (short axis, vertical long axis, horizontal long axis) and
polar maps of the left ventricle were created.
MPI analysis
Images were analysed with a commercially available
software solution (Cedars QPS/QGS, Cedars-Sinai Medical
Center, Los Angeles, CA, USA). We assessed reversible
perfusion defects which were identified as previously
reported [9, 10]. In summary, myocardial tomograms were
grouped into 20 segments for each patient. Segments were
graded by consensus of two experienced readers using the
following 5-point scoring system (0: normal; 1: equivocal;
2: moderate; 3: severe reduction in radioisotope uptake; and
4: absence of detectable tracer in a segment). A scan was
scored as abnormal if two or more segments had stress
scores ≥2. A reversible perfusion defect was defined as one
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in which a stress defect was associated with a rest score ≤1
or a stress defect score of 4 with a rest score of 2. Only
reversible defects were considered for further analysis as
ischaemia-driven patient management is most evidence-
based ascertaining best clinical practice.
A semi-automated summed rest and summed stress score
was obtained from QPS/QGS by adding the rest and stress
scores from the 20 segments. From this, a summed
difference score (SDS) was calculated as an index of the
ischaemia extent.
Invasive coronary angiography
Invasive coronary angiography was conducted according to
standard techniques. A coronary stenosis was defined as a
luminal narrowing of ≥50% based on visual rather than
quantitative evaluation, as this reflects daily clinical routine
in our [11] and most catheterization laboratories worldwide
[12].
Statistical analysis
Sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV) and accuracy were
calculated for MPI regarding detection of coronary artery
disease (CAD) (≥50% luminal narrowing). All statistical
analyses were performed using SPSS 19.0 (SPSS Inc.,
Chicago, IL, USA).
Results
All patients successfully underwent stress/rest imaging with
the CZT/CT camera and invasive coronary angiography
within 20.3 days (range −10 to 87 days) of the MPI (MPI
first in 62, angiography first in 4 patients). The patient
characteristics are shown in Table 1. Invasive coronary
angiography identified 139 coronary artery lesions with a
luminal diameter narrowing ≥50% in 106 vessels of 54
patients. Thus, prevalence of CAD in this population was
82%. The administered mean doses of 99mTc-tetrofosmin
for stress and rest imaging were 335±41 MBq (range 300–
440) and 980±109 MBq (range 900–1274). Pharmacolog-
ical stress was induced by adenosine in 59 (89%) and
dobutamine in 7 (11%) patients.
Per-patient comparison of MPI to invasive coronary
angiography
Visual per-patient analysis of MPI revealed 51 (77%)
reversible perfusion defects, whereas invasive coronary
angiography detected 54 patients (82%) with CAD (≥50%
luminal narrowing). Per-patient sensitivity, specificity, PPV,
NPV and accuracy of CZT/CT to predict CAD in invasive
coronary angiography were 87, 67, 92, 53 and 83%,
respectively (Fig. 1).
By use of a receiver-operating characteristic curve for
SDS a value of 2 was identified as the cutoff for best
predicting CAD in invasive coronary angiography. This
yielded a sensitivity, specificity, PPV, NPV and accuracy of
74, 67, 91, 36 and 73%, respectively (Fig. 2).
Discussion
The present study is the first to validate MPI by a novel
hybrid CZT/CT device integrating a latest generation CZT
Table 1 Patient baseline characteristics (n=66)
Characteristic Value
Male, n (%) 52 (79)
Age (years)
Mean±SD 63±11
Range 42–86
BMI (kg/m2)
Mean±SD 28±4
Range 18–41
Cardiovascular risk factors, n (%)
Obesity (BMI >30 kg/m2) 23 (35)
Diabetes mellitus 24 (36)
Smoking 14 (21)
Hypertension 55 (83)
Dyslipidemia 47 (71)
Positive family history 17 (26)
Clinical symptoms, n (%)
Typical angina pectoris 29 (44)
Atypical chest pain 4 (6)
Dyspnoea 11 (17)
No cardiac symptoms 29 (44)
Clinical findings, n (%)
Abnormal rest ECG 29 (44)
Abnormal stress ECG 31 (47)
Abnormal echocardiography 6 (9)
Previous cardiac events, n (%)
Myocardial infarction 18 (27)
Percutaneous coronary intervention 25 (38)
Stent implantation 22 (33)
Current cardiac medication, n (%)
Aspirin 55 (83)
Beta-blocker 40 (61)
ACE/angiotensin II inhibitor 43 (65)
Statin 54 (82)
BMI body mass index, ACE angiotensin-converting enzyme
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gamma camera onto a 64-slice CT scanner using invasive
coronary angiography as the standard of reference. This
new CZT/CT device allows obtaining attenuation corrected
MPI using CT X-ray based attenuation maps. Our results
document an excellent PPV (92%) and accuracy (83%) for
detection of CAD (≥50% luminal narrowing) using the new
device by visual assessment. Automated analysis with a
cutoff for SDS at a value of 2 yielded a slightly lower
sensitivity (74%) at a comparable PPV (91%).
Recent reports have evidenced that CZT cameras offer
excellent image quality (Fig. 3) and diagnostic accuracy
comparable to conventional SPECT despite reduced scan
duration [2, 4, 6]. Furthermore, CT attenuation correction
for high speed MPI with CZT detectors has recently been
validated [3], although by use of a stand-alone CT, while in
the present study this was integrated in the hybrid device.
Our results support the accuracy of CZT MPI for
detecting CAD with a high sensitivity and PPV. On the
other hand, however, the data for specificity and NPV are
much less solid due to the well-known referral bias as a
consequence of the awareness of SPECT MPI to rule out
CAD as a reliable gatekeeper for invasive coronary
angiography [11]. Thus, patients without ischaemia in
MPI are generally not referred to invasive coronary
angiography reducing the number of true negative MPI
findings leading to a decline in specificity over time [13]. In
addition, the relatively high prevalence of CAD in our
study may have contributed to the modest NPV. Despite this
phenomenon the value for specificity ranges well within the
values reported in the literature [14]. As the assessment of
true specificity of MPI is almost impossible, some authors
have suggested the normalcy rate as a surrogate for
specificity and NPV by calculating the rate of normal
MPI in patients with very low pre-test probability. We were
reluctant to adopt this concept as we felt that this would not
provide more solid ground to a real-life setting where
patients with less than 5% pre-test probability should not
undergo MPI according to current guidelines both from
nuclear cardiology [14] as well as from interventional
cardiologists [15]. Furthermore, the anatomical reference by
invasive coronary angiography has been recognized to be a
flawed gold standard for the functional ischaemia test MPI
[16]. Due to the improved spatial resolution of the CZT
detectors a better visualization of non-severe perfusion
defects due to endothelial dysfunction in the absence of
significant CAD may further affect specificity of this
device. In a recent large multicentre trial, invasively
assessed fractional flow reserve in coronary lesions has
Fig. 2 Sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV) and accuracy of SDS ≥2 (obtained
by semi-automated analysis from QPS/QGS) to predict angiographic
CAD
Fig. 3 MPI polar plots (left panel) showing inferior ischaemia (pink
area in the stress perfusion) and corresponding angiographic stenosis
(right panel) in the right coronary artery (arrow)
Fig. 1 Sensitivity, specificity, positive predictive value (PPV),
negative predictive value (NPV) and accuracy of visually assessed
MPI to predict angiographic CAD
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revealed that the majority of coronary lesions with 50–70%
narrowing do not confer any haemodynamic relevance and
for luminal narrowing of 70–90% functional relevance was
lacking in 40% of coronary lesions [17]. The specificity of
CZT MPI of 67% clearly reflects this large gap between
coronary anatomy and its pathophysiological consequence
rather than a modest performance of attenuation corrected
CZT MPI. The ultimate metric may be outcome and with
regard to outcome prediction by MPI the added value of
attenuation correction has been recently established [18].
The main advancement of the new CZT cameras [19] is the
more than fivefold reduction in scan time [4] or activity
[20] at preserved accuracy. Several other applications allow
one to take even more complete advantage of the refine-
ments offered by the new cameras which may further
enhance the clinical importance of MPI. Although not
applied in the present study, the geometry of the detector
array allowing acquisition of all angles simultaneously
facilitates breath-hold triggering, which can assist in
discrimination of artefacts from true hypoperfusion similar
to attenuation correction [21]. Furthermore, left ventricular
dyssynchrony can be assessed with a scan time of 5 min,
which may be repeatedly acquired [5] to enable optimiza-
tion of pacing parameters in chronic resynchronization
treatment for heart failure.
In conclusion, this is the first study confirming the
feasibility and clinical validity of rapid MPI versus invasive
coronary angiography on a novel CZT/CT device, which
implements the latest semiconductor detectors, innovative
reconstruction algorithms with attenuation correction and
compact design geometry. Our results show a high PPV and
accuracy for detection of angiographically documented
CAD.
It could be perceived as a potential limitation that we did
not perform quantitative coronary angiography to assess
lesion severity. However, in real life visual assessment is
performed mainly for ease of use and the relevant outcome
studies support the validity of expert visual grading [12]. In
addition and as mentioned above, visualization of coronary
anatomy by invasive coronary angiography may constitute
a suboptimal gold standard, while a comparison with
conventional SPECT may appear favourable. In daily
clinical routine, however, patients with ischaemia in MPI
are eventually referred for invasive angiography and, thus,
comparison of the two methods is pertinent. Furthermore,
we have included a broad range of BMI (18–41) without in-
depth analysis with regard to its impact on image quality as
well as potential under- and overcorrection by implemented
attenuation correction algorithms as this would have been
beyond the scope of the present study.
Finally, Giorgetti et al. [22] have found differential
washout of 99mTc-tetrofosmin from normal versus ischaemic
myocardial regions advocating a short interval from injection
to SPECT scanning, whereas we used a 45 to 60 min interval
(according to EANM guidelines [7]) allowing up to 90 min
if logistically needed. Thus, theoretically we may have
underestimated ischaemic segments, although Giorgetti et al.
based their observation on 15 versus 45 min, where an effect
of delaying image acquisition from 60 to 90 min has not
been reported so far.
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